Annual Total Long Term Liabilities
$237.98 M
-$8.49 M-3.45%
December 31, 2023
Summary
- As of February 7, 2025, CRSP annual total long term liabilities is $237.98 million, with the most recent change of -$8.49 million (-3.45%) on December 31, 2023.
- During the last 3 years, CRSP annual total long term liabilities has risen by +$168.50 million (+242.55%).
- CRSP annual total long term liabilities is now -3.45% below its all-time high of $246.47 million, reached on December 31, 2022.
Performance
CRSP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$226.66 M
-$4.42 M-1.91%
September 30, 2024
Summary
- As of February 7, 2025, CRSP quarterly total long term liabilities is $226.66 million, with the most recent change of -$4.42 million (-1.91%) on September 30, 2024.
- Over the past year, CRSP quarterly long term liabilities has dropped by -$11.31 million (-4.75%).
- CRSP quarterly long term liabilities is now -13.85% below its all-time high of $263.09 million, reached on September 30, 2016.
Performance
CRSP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CRSP Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -4.8% |
| 3 y3 years | +242.6% | +6.6% |
| 5 y5 years | +244.5% | +363.2% |
CRSP Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +2.3% | -10.3% | at low |
| 5 y | 5-year | -3.5% | +242.6% | -10.3% | +293.7% |
| alltime | all time | -3.5% | +3644.7% | -13.8% | +363.2% |
CRISPR Therapeutics AG Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $226.66 M(-1.9%) |
| Jun 2024 | - | $231.08 M(-2.1%) |
| Mar 2024 | - | $236.09 M(-0.8%) |
| Dec 2023 | $237.98 M(-3.4%) | $237.98 M(-4.0%) |
| Sep 2023 | - | $247.80 M(-0.1%) |
| Jun 2023 | - | $248.15 M(+2.3%) |
| Mar 2023 | - | $242.67 M(-1.5%) |
| Dec 2022 | $246.47 M(+6.0%) | $246.47 M(-0.8%) |
| Sep 2022 | - | $248.53 M(-1.6%) |
| Jun 2022 | - | $252.57 M(+2.0%) |
| Mar 2022 | - | $247.56 M(+6.5%) |
| Dec 2021 | $232.53 M(+234.7%) | $232.53 M(+9.4%) |
| Sep 2021 | - | $212.60 M(+8.6%) |
| Jun 2021 | - | $195.80 M(+182.5%) |
| Mar 2021 | - | $69.32 M(-0.2%) |
| Dec 2020 | $69.47 M | $69.47 M(+20.7%) |
| Sep 2020 | - | $57.57 M(-6.2%) |
| Jun 2020 | - | $61.36 M(-7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $66.12 M(-5.8%) |
| Dec 2019 | $70.22 M(+1.7%) | $70.22 M(+43.5%) |
| Sep 2019 | - | $48.93 M(-48.6%) |
| Jun 2019 | - | $95.15 M(+6.1%) |
| Mar 2019 | - | $89.67 M(+29.8%) |
| Dec 2018 | $69.08 M(+0.1%) | $69.08 M(-0.3%) |
| Sep 2018 | - | $69.31 M(-0.3%) |
| Jun 2018 | - | $69.50 M(-0.3%) |
| Mar 2018 | - | $69.72 M(+1.0%) |
| Dec 2017 | $69.00 M(-23.4%) | $69.00 M(-24.4%) |
| Sep 2017 | - | $91.24 M(-0.1%) |
| Jun 2017 | - | $91.36 M(+1.2%) |
| Mar 2017 | - | $90.26 M(+0.2%) |
| Dec 2016 | $90.12 M(-49.5%) | $90.12 M(-65.7%) |
| Sep 2016 | - | $263.09 M(+241.1%) |
| Jun 2016 | - | $77.12 M(-56.8%) |
| Dec 2015 | $178.39 M(+2707.1%) | $178.39 M |
| Dec 2014 | $6.36 M | - |
FAQ
- What is CRISPR Therapeutics AG annual total long term liabilities?
- What is the all time high annual total long term liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual total long term liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly long term liabilities year-on-year change?
What is CRISPR Therapeutics AG annual total long term liabilities?
The current annual total long term liabilities of CRSP is $237.98 M
What is the all time high annual total long term liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total long term liabilities is $246.47 M
What is CRISPR Therapeutics AG annual total long term liabilities year-on-year change?
Over the past year, CRSP annual total long term liabilities has changed by -$8.49 M (-3.45%)
What is CRISPR Therapeutics AG quarterly total long term liabilities?
The current quarterly long term liabilities of CRSP is $226.66 M
What is the all time high quarterly long term liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total long term liabilities is $263.09 M
What is CRISPR Therapeutics AG quarterly long term liabilities year-on-year change?
Over the past year, CRSP quarterly total long term liabilities has changed by -$11.31 M (-4.75%)